Distaso, Guglielmo (A.A. 2020/2021) The paying twice and the price regulationi in the pharmaceutical industry: Sovaldi and Sars Cov-2 vaccines cases. Tesi di Laurea in Markets, regulations and law, Luiss Guido Carli, relatore Giuseppe Colangelo, pp. 148. [Master's Degree Thesis]

Preview

PDF (Full text) Download (3MB) | Preview

Abstract/Index

Pharmaceutical industry and regulation in the market. Pharmaceutical industry. An economic analysis of pharmaceutical industry. Sars Cov-2 and pharmaceutical indestry. Pharmaceutical regulation systems. IPR regimes, innovation, drugs and prices: USA versus Italy. Intellectual property rights regimes: Bayh-Dole Act and professor’s privilege. Systems of intellectual property rights. Bayh-Dole Act: literature review. Professor’s privilege: literature review. Literature review on the differences of the IPRs regimes. Innovation, drugs and prices: USA versus Italy. Innovation and pharmaceutical industry. Is science a public good or a private good? Pharmaceutical innovation. Price regulation and composition of prices. Paying-twice. Gilead’s Sofosbuvir and Sars Cov-2 vaccines cases. Sovaldi case: pharmasset, gilead and US senate. Sars Cov-2 vaccines: Pfizer and AstraZeneca. Public utility and IPRs regimes change: a non-solution. A change in the pricing: the consequences.

References

Bibliografia: pp. 133-147.

Thesis Type:	Master's Degree Thesis
Institution:	Luiss Guido Carli
Degree Program:	Master's Degree Programs > Master's Degree Program in Management, English language (LM-77)
Chair:	Markets, regulations and law
Thesis Supervisor:	Colangelo, Giuseppe
Thesis Co-Supervisor:	Arnaudo, Luca
Academic Year:	2020/2021
Session:	Autumn
Deposited by:	Alessandro Perfetti
Date Deposited:	09 May 2022 10:55
Last Modified:	09 May 2022 10:55
URI:	https://tesi.luiss.it/id/eprint/32187

Downloads

Repository Staff Only

View Item